Molecular analysis of etiological factors and malignant degrees for non-small cell lung cancer

非小细胞肺癌病因及恶性程度的分子分析

基本信息

项目摘要

74 resected squamous cell carcinomas (sqs) and 239 adenocarcinomas were analyzed for p53 mutation : Any relationships between tumor location of sqs or subtype of adenocarcinomas, smoking, and p53 mutation patterns were then examined focusing on varying etiological factors. Our hypothesis was, that G→T transversion of p53 gene is caused by direct action of carcinogens contained in tobacco smoke on DNA, and that G→A transition at CpG (CpG→A) sites of the gene is caused by endogenous mechanisms. The same adenocarcinoma cases were also analyzed to determine what type of combined mutation status on p53 and k-ras affects malignancy of the tumors more strongly.Results:1) Sqs were divided into three types by location - central, intermediate and periphera l; the highest frequencies of CpG→A in the central type, G→T in the intermediate and other mutations in the peripheral, were observed. 2)Adenocarcinomas were divided into five types - hobnail, columnar, goblet, polygonal and mixed. Of these, the hobnail type showed a low p53 mutation frequency with the highest CpG→A rate, the columnar and polygonal types had a high mutation frequency with the highest G→T rates, and the mixed type showed intermediate frequency of p53 with the highest other base change. 3)Five year survival was the highest for adenocarcinomas with the combination of non-mutated p53 and k-ras, followed by the combination of mutated p53 and non-mutated k-ras, and then the combination of non-mutated p53 and mutated k-ras, with the combination of mutated p53 and k-ras having the lowest survival.The results show that etiological factors vary depending on locations of sqs and subtype of adenocarcinomas ; the worst malignancy was adenocarcinomas with the combined status on mutated p53 and k-ras.
对74例鳞状细胞癌(SQS)和239例腺癌进行了p53突变分析:然后重点研究了不同的病因,分析了SQS的肿瘤位置与腺癌亚型、吸烟和p53突变模式之间的关系。我们的假设是,P53基因的G-→T颠倒是由烟草烟雾中含有的致癌物直接作用于脱氧核糖核酸引起的,而该基因CpG(CpG-→A)位点的G-→A转换是由内源性机制引起的。结果:1)鳞癌按部位分为中央型、中间型和周围型L,中央型、中间型和周围型突变频率最高,中间型和外周型突变频率最高。2)腺癌分为鞋钉型、柱状型、杯状型、多角型和混合型。其中,鞋钉型突变率低,CpG→A率最高,柱状型和多边形型突变率高,G→T率最高,混合型突变率中等,其他碱基改变最高。3)非突变P53和k-ras联合表达的腺癌5年生存率最高,其次是突变P53和非突变k-ras联合表达,其次是非突变P53和突变k-ras结合表达,而突变P53和k-ras结合表达的腺癌5年生存率最低。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors
  • DOI:
    10.1111/j.1349-7006.2004.tb03212.x
  • 发表时间:
    2004-04
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Yasuhito Kobayashi;Y. Tokuchi;T. Hashimoto;M. Hayashi;H. Nishimura;Y. Ishikawa;K. Nakagawa;Y. Sato;Atsushi Takahashi;E. Tsuchiya
  • 通讯作者:
    Yasuhito Kobayashi;Y. Tokuchi;T. Hashimoto;M. Hayashi;H. Nishimura;Y. Ishikawa;K. Nakagawa;Y. Sato;Atsushi Takahashi;E. Tsuchiya
p53 mutation spectra for squamous cell carcinomas at different levels of human bronchial branches
  • DOI:
    10.1002/ijc.21877
  • 发表时间:
    2006-08
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Takuo Shimmyo;T. Hashimoto;Yasuhito Kobayashi;Y. Miyagi;Y. Ishikawa;K. Nakagawa;H. Osada;E. Tsuchiya
  • 通讯作者:
    Takuo Shimmyo;T. Hashimoto;Yasuhito Kobayashi;Y. Miyagi;Y. Ishikawa;K. Nakagawa;H. Osada;E. Tsuchiya
肺癌、病理診断に役立つ分子病理学・10、シリーズ最新医学講座・II.
对肺癌病理诊断有用的分子病理学/10,最新医学课程系列/II.
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    石川雄一;土屋永寿
  • 通讯作者:
    土屋永寿
ADAM8 as a novel serological and histochemical marker for lung cancer
  • DOI:
    10.1158/1078-0432.ccr-04-1436
  • 发表时间:
    2004-12-15
  • 期刊:
  • 影响因子:
    11.5
  • 作者:
    Ishikawa, N;Daigo, Y;Nakamura, Y
  • 通讯作者:
    Nakamura, Y
Kobayashi K, Tokuchi Y, Hashimoto T.M Tsuchiva E.et al.: "Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors"Cancer Science. (in press).
Kobayashi K、Tokuchi Y、Hashimoto T.M Tsuchiva E.等人:“用于强化神经内分泌肺肿瘤组织学亚分类的分子标记”癌症科学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUCHIYA Eiju其他文献

TSUCHIYA Eiju的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUCHIYA Eiju', 18)}}的其他基金

Prediction of therapy effects and cancer susceptibility for lung cancers by combined data of histology, polymorphism and gene alterations
通过组织学、多态性和基因改变的综合数据预测肺癌的治疗效果和癌症易感性
  • 批准号:
    18590358
  • 财政年份:
    2006
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Analysis of peptide antibodies derived from EGFR in non-small cell carcinoma
非小细胞癌中 EGFR 衍生的肽抗体分析
  • 批准号:
    19790571
  • 财政年份:
    2007
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Anti-idiotype monoclonal antibody in the diagnosis and trectment of non-small cell carcinoma of the long
抗独特型单克隆抗体在长发非小细胞癌诊断和治疗中的应用
  • 批准号:
    02454324
  • 财政年份:
    1990
  • 资助金额:
    $ 2.11万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
INVASIVE & METASTATIC NON SMALL CELL CARCINOMA CELLS EXHIBIT P53 ABNORMALITIES
侵入性
  • 批准号:
    3871363
  • 财政年份:
  • 资助金额:
    $ 2.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了